Michael J. Ashton - Concepedia

Author

Michael J. Ashton

Barking and Dagenham College

Also Known As

M J Ashton, M. ASHTON, M. J. ASHTON, M.J. Ashton, MICHAEL J. ASHTON, Michael J. Ashton

Publications

531

Citations

H-Index

Concepts

All Affiliations

Barking and Dagenham College

About

Michael J. Ashton is an author at Barking and Dagenham College specializing in medicinal chemistry, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	236
2	Biochemistry	5	5	247
3	Natural Sciences	4	4	197
4	Allergy	2	2	151
5	Health Sciences	1	1	50

Michael J. Ashton

Publications

464

Citations

H-Index

Page 1

	Year	Citations
Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogs Michael J. Ashton, David Cook, Garry Fenton, Journal of Medicinal Chemistry Antiparasitic AgentPde IvBiological ActivitiesPharmacotherapyPharmaceutical Chemistry	1994	112
Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP‐specific phosphodiesterase: comparison with rolipram John E. Soilness, Christopher Maslen, Stephen E. Webber, British Journal of Pharmacology	1995	85
New perspectives in lead generation II: Evaluating molecular diversity Michael J. Ashton, Michael Jaye, Jon S. Mason Drug Discovery Today Hit IdentificationMolecular BiologyLead IdentificationLead Generation IiMolecular Diversity	1996	54
The absorption, metabolism and excretion of disodium cromoglycate in nine animal species Michael J. Ashton, Barbara J. Clark, K. M. Jones, Toxicology and Applied Pharmacology Animal PhysiologyBiochemistryFood DigestionPhysiologyDisodium Cromoglycate	1973	50
Anti-inflammatory 17β-Thioalkyl-16α,17α-ketal and -acetal Androstanes: A New Class of Airway Selective Steroids for the Treatment of Asthma Michael J. Ashton, Christopher Lawrence, Jan‐Anders Karlsson, Journal of Medicinal Chemistry AsthmaInflammatory Lung DiseaseLung InflammationImmunologyGlucocorticoid	1996	39
Acyl-CoA: cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT Neil V. Harris, Andrew W. Bridge, Raymond C. Bush, Journal of Medicinal Chemistry Mevalonate Derivative 2PharmacotherapyLow DensityChemical BiologyPharmaceutical Chemistry	1992	38
RP 70676: A potent systematically available inhibitor of acyl-CoA:cholesterol O-acyl transferase (ACAT) Michael J. Ashton, A. W. BRIDGE, Raymond C. Bush, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryOxysterolLipid SynthesisBiochemistry	1992	27
Heterocyclic analogs of chlorcyclizine with potent hypolipidemic activity Michael J. Ashton, A. Ashford, A. Loveless, Journal of Medicinal Chemistry	1984	22
Synthesis of 6-Aryl-4-hydroxypiperidin-2-ones and a Possible Applications to the Synthesis of a Novel HMG-CoA Reductase Inhibitor John B. Taylor, Michael J. Ashton, Susan J. Hills, Heterocycles Medicinal ChemistryDerivative (Chemistry)HeterocyclicAldo-keto ReductaseBiochemistry	1989	20
Acyl-CoA:Cholesterol<i>O</i>-Acyltransferase (ACAT) Inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1<i>H</i>-imidazoles as Potent Inhibitors of ACAT Peter C. Astles, Michael J. Ashton, Andrew W. Bridge, Journal of Medicinal Chemistry	1996	17

Page 1